MedTrace Logo

Comparison the Effects of Etomidate and Sevoflurane During Electroconvulsive Therapy

NCT02500225 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-01-23

No results posted yet for this study

Summary

The purpose of the study was to investigate the effects of etomidate or sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles.

Conditions

  • Anesthesia
  • ECT

Interventions

DRUG

Etomidate

0.2 mg/kg etomidate

DRUG

Sevoflurane

8% Sevoflurane

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Principal Investigators

  • Ulku Ozgul, MD · Inonu University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-02-28
Completion
2017-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02500225 on ClinicalTrials.gov